BackImpact BioMedical Overview

Impact BioMedical Current Cash

Impact BioMedical's current cash is $21K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$21000.00
↑ 75.00% YoYΔ $9000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Impact BioMedical Current Cash History

Loading

Impact BioMedical vs. peers: Current Cash Comparison

Loading

Impact BioMedical Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Impact BioMedical (IBO) FAQ

Impact BioMedical's current cash stands at $21K as of September 2026. That compares with $12K in the prior-year period — up 75.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Impact BioMedical reported $21K in current cash versus $12K a year earlier — a 75.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $12K in the prior-year period — up 75.0% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Impact BioMedical's current cash evolved across reporting periods, while the comparison chart places IBO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current cash is commonly used to spot outliers. Impact BioMedical's reading of $21K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.